Abstract
Introduction and Aims: To assess the 10-year outcome of knee arthroplasty surgery in a generalist setting, across a single UK health region.
Method: The Trent Arthroplasy Audit Group has been collecting prospective data on primary knee replacements since 1990. 4677 primary knee replacements were performed in the period 1990–92. A validated self-administered questionnaire, including a EuroQol health evaluation questionnaire, was mailed to all surviving patients. The mean age at the time of surgery was 70 years.
Results: Thirty-nine percent of the patients had died by 10 years. Responses were received from 87% of patients. Eighty-two percent of patients had been satisfied with the result of their knee replacement. Twenty-one percent of patients felt that it was not as good as they had been led to believe before surgery. Forty percent of patients had had problems with their knee in the 10 years since surgery. Twenty-one percent had had some form of surgical intervention. Eighty-two percent of patients were taking medication to alleviate pain in their replaced knee.
Eighteen percent complained of constant pain in this knee. When the pain occurred it was described as being severe in 16% and moderate in 40%. Most patients were on prescribed medication, but had not been referred to a surgeon to identify if there was a problem with their implant. The revision rate, for all causes at 10 years was 13%.
Conclusion: The results of knee arthroplasty at 10 years are disappointing. Patients’ responses indicate that previously successful knees are becoming painful. At the present time there appears to be inadequate long-term follow-up/re-referral of patients and surgeons have a high threshold for revision surgery. More detailed clinical examination is planned for this group of patients.
These abstracts were prepared by Editorial Secretary, George Sikorski. Correspondence should be addressed to Australian Orthopaedic Association, Ground Floor, The William Bland Centre, 229 Macquarie Street, Sydney, NSW 2000, Australia.
At least one of the authors is receiving or has received material benefits or support from a commercial source.